comparemela.com

Latest Breaking News On - French medtech - Page 19 : comparemela.com

T-Heart Appoints Sarah Sorrel as Independent Board Member

T-Heart, a medtech company developing a truly novel and differentiated transcatheter tricuspid prosthetic heart valve specifically designed for tricuspid regurgitation, today announced it has appointed

CARMAT Announces the Resumption of Commercial Implants of its Aeson® Artificial Heart Is Now Effective

CARMAT Announces the Resumption of Commercial Implants of its Aeson® Artificial Heart Is Now Effective
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

CARMAT announces that it has received regulatory approvals to resume its clinical study in France

CARMAT (FR0010907956, ALCAR), the designer and developer of Aeson®, the world’s most advanced total artificial heart, designed to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, announced today that it has been granted the necessary regulatory approvals from the .

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.